Tom Baker Cancer Centre/Arthur J.E. Child Comprehensive Cancer Centre
Welcome,         Profile    Billing    Logout  
 2 Trials 
8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Storek, Jan
NCT03456817: HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis

Recruiting
2
200
Canada
Treatment Arm - high dose ATG, Control Arm - standard of care
AHS Cancer Control Alberta
Graft-versus-host-disease, Relapse
09/26
09/26
Faruqi, Muhammad
NCT03550391: Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Recruiting
3
206
Canada, US
Memantine, Hippocampal-avoidant (HA-WBRT) Radiotherapy, Stereotactic Radiosurgery (SRS)
Canadian Cancer Trials Group, Alliance for Clinical Trials in Oncology, NRG Oncology
Brain Metastases
06/27
12/27
NCT04474925: Pre- Versus Post-operative SRS for Resectable Brain Metastases

Recruiting
3
88
Canada
Brain Surgery, Stereotactic Radiosurgery, SRS
AHS Cancer Control Alberta
Brain Metastases
09/25
08/26
UNSCARRed, NCT03737721: The Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy

Active, not recruiting
2
20
Canada
Avelumab and Radical radiotherapy
AHS Cancer Control Alberta, EMD Serono, Alberta Cancer Foundation
Squamous Cell Carcinoma of the Skin
11/22
12/24
Yip, Steven
CCTG PR21, NCT04663997: 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

Active, not recruiting
2
200
Canada
177Lu-PSMA-617, Docetaxel
Canadian Cancer Trials Group, Prostate Cancer Canada, Novartis Pharmaceuticals
Prostate Cancer
06/25
12/25
NCT02355171: Personalize My Treatment (PMT) Registry

Recruiting
N/A
10000
Canada
Exactis Innovation
Cancer
07/25
07/25
NCT05709535: PSMA-PET/CT Registry

Terminated
N/A
128
Canada
[18F]-PSMA-1007
AHS Cancer Control Alberta
Prostate Cancer
11/24
11/24
Lee, Sangjune
NCT05370144: A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma

Recruiting
N/A
42
Canada
Hypofractionated radiotherapy
AHS Cancer Control Alberta
Esophageal Cancer
02/27
02/28

Download Options